Over-the-counter antihistamines and a prescription anti-inflammatory drug both have a small benefit in reducing long Covid fatigue among people receiving care from specialist long Covid clinics, according to new findings from a large clinical trial led by UCL (University College London) and UCLH.

Solving problems by harnessing the natural adaptive capacity of bacteria. This is the challenge taken up by a research team coordinated by INRAE and involving Grenoble Alpes University Hospital, Université Grenoble Alpes and the French Alternative Energies and Atomic Energy Commission (CEA). By tracking the growth curves of the bacterium Escherichia coli, the researchers were able to distinguish between mild and severe forms of COVID-19. These results, published in Cell Systems, pave the way for simple and low-cost diagnostic methods.

Years of progress in reducing benzodiazepine prescribing among older Americans stalled after the onset of the COVID-19 pandemic, according to a decade-long national study from Columbia University Mailman School of Public Health and Columbia University Irving Medical Center.

Ten weeks of cognitive rehabilitation can help people with long Covid symptoms such as brain fog achieve their goals in returning to work and hobbies, finds a new clinical trial led by University College London (UCL) researchers.

COVID-19 vaccine boosters not only protect against SARS‑CoV‑2 – the virus behind the most recent pandemic – but may also help protect against some future coronaviruses that risk spreading from animals to humans, Cambridge researchers have shown. In a related study, the team has shown that an individual’s first exposure to SARS‑CoV‑2 ‘locks in’ their immune response, impeding their ability to respond to future variants, even when vaccinated.